Intelligent Bio Solutions Inc.
corporate_fare Company Profile
Intelligent Bio Solutions Inc. (NASDAQ:INBS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 36 items for INBS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-09, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for INBS spans 8-K, 10-K.
Recent high-impact activity:
- INBS Submits FDA 510(k) for Codeine Detection System with 98%+ Accuracy Data
- Intelligent Bio Solutions Submits FDA 510(k) for Fingerprint Drug Screening System
- INBS Secures $5M Private Placement with Warrants Contingent on FDA 510(k) Clearance
- Intelligent Bio Solutions Reports 98.2% Accuracy in Codeine Study, Accelerates FDA 510(k) Submission to September
- Intelligent Bio Solutions Raises Up to $15M in At-the-Market Private Placement
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for INBS, detected from its recent SEC filings · based on capital-structure filings through 2026-09-02.
Capital Raise Update · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →